(LEAD) Regulator concludes 'intentional' accounting breach by Samsung BioLogics
(ATTN: UPDATES with regulator's ruling in first 2 paras; CHANGES headline)
SEOUL, July 12 (Yonhap) -- The financial regulator said Thursday it has concluded that a 2015 accounting breach by Samsung BioLogics Co. was intentional and the biopharmaceutical company clearly violated accounting rules.
The ruling by the Financial Services Commission (FSC) is expected to deal a serious blow to Samsung BioLogics, which has strongly denied allegations of accounting breach.
In May, financial authorities gave a preliminary notice to Samsung BioLogics that it broke accounting rules in 2015.
The regulatory probe centers on questions about the biopharmaceutical company's sudden profits in 2015 after years of losses. Samsung BioLogics reported a net profit of 1.9 trillion won (US$1.72 billion) that year after changing the method used to calculate the value of its affiliate, Samsung Bioepis.
Samsung BioLogics has claimed that the change was in line with international accounting standards.
(END)
-
1 
(LEAD) S. Korea to provide loans worth 100 tln won to innovative firms, SMEs
-
2 
Samsung to launch first 5G smartphone on April 5
-
3 
Five dead after car falls into sea on east coast
-
4 
White House: Earlier sanctions on N. Korea remain in place
-
5 
Actress Park Han-byul apologizes for husband's involvement in growing sex scandal
-
1 
(4th LD) N. Korean staff return to inter-Korean liaison office
-
2 
Trump was open to easing sanctions at Hanoi summit: N.K. official
-
3 
N.K. denounces Seoul over slow progress in implementing inter-Korean deals
-
4
(3rd LD) N. Korean staff return to inter-Korean liaison office
-
5
(2nd LD) Dozens of S. Korean officials head to joint liaison office after N. Korea's abrupt pullout
